The present invention relates to 2-(benzoylamino)benzoic acid derivatives of the formula I
1
wherein the variants Ar, X and R are as described in the specification. The said compounds modulate the activity of peroxisome proliferator-activated receptors (PPAR) &agr; and/or &ggr;, and are predicted to be useful in the treatment of metabolic diseases, e.g. type II diabetes.
本发明涉及式I1的2-(苯甲酰
氨基)
苯甲酸衍
生物,其中变体Ar、X和R如规范中所述。所述化合物调节
过氧化物酶增殖物激活受体(
PPAR)α和/或γ的活性,并预计可用于治疗代谢性疾病,例如II型糖尿病。